Latest Investment Analysis

Investing Articles

Around £22 now, GSK’s share price looks 50% undervalued to me after strong 2025 results

23 February, 2026 | Simon Watkins

With specialty medicines driving growth, cash generation strengthening and the pipeline accelerating, GSK’s fair value looks far above today’s price to me.

Read more »

Editor’s Choice

Investing Articles

Just released: the 3 best growth-focused stocks to consider buying in January [PREMIUM PICKS]

6 January, 2026 | Mark Rogers

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due to a combination of business performance and potentially attractive share valuation.

Read more »